GLP-3-RT
GLP-3-RT
A triple-receptor research compound activating GIP, GLP-1, and glucagon receptors simultaneously — currently the most-watched molecule in metabolic science. The glucagon receptor component expands the mechanism beyond incretin pathways into energy expenditure research.
A triple-receptor research compound activating GIP, GLP-1, and glucagon receptors simultaneously — currently the most-watched molecule in metabolic science. The glucagon receptor component expands the mechanism beyond incretin pathways into energy expenditure research.
$179.00
$179.00
$179.00
Research use only
For scientific research, and in-vitro testing only. Not for human or veterinary use.
How should I store this peptide?
What purity are your peptides?
Research Use Only [Disclaimer]
Fast Dispatch
Orders ship within 24-48 hours
Fast Dispatch
Orders ship within 24-48 hours
Discreet Shipping
Plain packaging, no branding
Secure Checkout
SSL + Stripe encrypted
The Science
The Science
Overview
Storage
Compound Data
What it is
A triple-receptor research compound activating GIP, GLP-1, and glucagon receptors simultaneously — currently the most-watched molecule in metabolic science.
Why it's studied
GLP-3-RT extends the incretin research framework by adding glucagon receptor activity, which opens energy expenditure into the mechanism alongside the established incretin pathways. It's the first triple agonist to reach mid-stage research and represents the leading edge of the category.
Key research findings
Most significant metabolic marker improvements ever recorded in the incretin class (Phase 2 research)
Documented improvements in HbA1c, lipid profile, and hepatic fat markers
Triple-receptor mechanism unique among research compounds in current development
Overview
Storage
Compound Data
What it is
A triple-receptor research compound activating GIP, GLP-1, and glucagon receptors simultaneously — currently the most-watched molecule in metabolic science.
Why it's studied
GLP-3-RT extends the incretin research framework by adding glucagon receptor activity, which opens energy expenditure into the mechanism alongside the established incretin pathways. It's the first triple agonist to reach mid-stage research and represents the leading edge of the category.
Key research findings
Most significant metabolic marker improvements ever recorded in the incretin class (Phase 2 research)
Documented improvements in HbA1c, lipid profile, and hepatic fat markers
Triple-receptor mechanism unique among research compounds in current development
PEPTIDES
PEPTIDES
You Might also like
You Might also like
Add these popular peptides to your order now
Add these popular peptides to your order now
Best Seller
Weight Loss
Retatrutide
The most powerful weight loss peptide studied, with clinical trials showing up to 24% body weight reduction in 48 weeks.
Best Seller
Weight Loss / Muscle
Tesamorelin
A GHRH analogue clinically proven to reduce visceral belly fat by 15-18% over 26 weeks.
Best Seller
ENERGY
MOTS-C
A mitochondrial peptide that enhances glucose metabolism by 15-25% and boosts endurance capacity by up to 65%.
Best Seller
RECOVERY
BPC 157
The "wolverine peptide" demonstrating 50-70% accelerated healing in tendon, muscle, and ligament injury models.
Best Seller
RECOVERY
TB 500
A tissue repair peptide demonstrating 40-60% faster recovery times in injury models through enhanced cell migration and healing.
Best Seller
SKIN
GHK CU
A copper peptide complex that increases collagen synthesis by up to 70%, promoting skin firmness and tissue regeneration.
FAQ
FAQ